Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. AMENDMENT TO EXCLUSIVE...Exclusive License Agreement • July 19th, 2021 • Locust Walk Acquisition Corp. • Pharmaceutical preparations • California
This amendment (the “Amendment”) is entered into as of July 12, 2021 (the “Effective Date”), by and between The Regents of the University of California, a California corporation, acting through its University of California, San Francisco Office of Technology Management (“UCSF”) and eFFECTOR Therapeutics, Inc., a Delaware corporation (the “Company”, together with UCSF, the “Parties”), for the purpose of amending the Exclusive License Agreement for UCSF Case No(s). 2013-017 and 2012-205 (the “License Agreement”), dated as of May 10, 2013, by and between UCSF and the Company.
